The medicine, called ocrelizumab, is normally given as an infusion through a vein - a process that can take up to four hours in hospital. The new way to give the drug will help free up patients ...

Ocrevus (ocrelizumab) is a prescription drug that’s used to manage certain types of multiple sclerosis. Ocrevus comes as an intravenous (IV) infusion. Ocrevus contains the active ingredient ...

There is growing clinical evidence that aHSCT can treat RRMS more effectively than DMTs. However, as most data is registry-based and previous trials did not directly compare aHSCT with the most ...

But the medication ocrelizumab, which helps to prevent relapses and slow the progression of MS, has now been approved as an injection and the first dose was given at Morriston Hospital.